Search

Summary

From the long path through preclinical development, entering the regulatory field of interactions for human clinical trials can sometimes feel like you are walking into the lion’s den. This chapter guides you through an understanding of how to interact and how to prepare for FDA meetings so that they are on your side rather than fighting you. The common goals of companies and the FDA are highlighted here. Specific issues with identifying the appropriate regulatory approval pathway are discussed here with cautionary case studies. Complex new technologies which combine diagnostics and drugs, or devices and software, or AI-based dynamic software are reviewed here. The best approach to the appropriate regulatory pathway will be clear after reading this chapter. Case studies are used to show successful pathways taken by cutting-edge developments, such as cell-based therapy.

The objective of this work is to study the static and dynamic occlusion of dentitions in a Class III molar relationship to determine what might be the indications for treatment that would leave buccal segments in this position, and to evaluate the occlusal adaptions that would be needed to make it functionally acceptable.

Search Results

Refine search

Refine search

Actions for selected content:

2 results

6 - The regulated market: gateway through the FDA

Summary

Therapeutic Class III molar occlusion

Search Results

Refine search

Refine search

Actions for selected content:

Save Search

2 results

6 - The regulated market: gateway through the FDA

Summary

Therapeutic Class III molar occlusion